KarthikDeepakNathMD

PubMed

• Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma.
  Lesokhin, A., Nath, K., Shekarkhand, T., Nemirovsky, D., Derkach, A., Costa, B., Nishimura, N., Farzana, T., Rueda, C., Chung, D., Landau, H., Lahoud, O., Scordo, M., ...> ;Research Square. 2024 Feb 7
• 1 citations
  Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
  Karthik Nath, Kristen Peterson, Samantha Brown, Sean Devlin, Natasia Rodriguez, Juliet Barker, Sergio Giralt, Boglarka Gyurkocza, Ann Jakubowski, Esperanza Papadopoulo...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• 2 citations
  CAR T-Cell Therapy for Multiple Myeloma: A Clinical Practice-Oriented Review.
  Norah Layla Sadek, Bruno Almeida Costa, Karthik Nath, Sham Mailankody> ;Clinical Pharmacology and Therapeutics. 2023 Dec 1
• Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
  Karthik Nath, Jasme Lee, Theresa A Elko, Lauren Levy, Elaina Preston, Sean M Devlin, Doris M Ponce, Richard J Lin, Brian C Shaffer, Christina Cho, Ioannis Politikos, A...> ;American Journal of Hematology. 2023 Dec 1
• 12 citations
  CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
  Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, M Lia Palomba, Gunjan Shah, Parastoo Dahi, Richard J Lin, Michael Scordo, Miguel-Angel Perales, Roni Shouval, ...> ;Nature Medicine. 2023 Jul 1
• 2 citations
  The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies.
  Karthik Nath, Sham Mailankody, Saad Z Usmani> ;Hematology/oncology Clinics of North America. 2023 Dec 1
• 22 citations
  Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
  Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T Melnekoff, Yogita Ghodke-Puranik, Gunjan L Shah, Alexander Lesokhin, Serg...> ;Blood. 2023 Feb 16
• 8 citations
  GPRC5D as a novel immunotherapeutic target in multiple myeloma.
  Karthik Nath, Bruno A Costa, Sham Mailankody> ;Nature Reviews. Clinical Oncology. 2023 May 1
• 1 citations
  Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma.
  Karthik Nath, Kitsada Wudhikarn, Ana Alarcon Tomas, Miguel-Angel Perales> ;Expert Opinion on Drug Safety. 2023 Jan 1
• A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
  Karthik Nath, Tala Shekarkhand, Meghan Salcedo, Andriy Derkach, Siobhan Rueda, Aisara Chansakul, Malin Hulcrantz, Neha Korde, Urvi A Shah, Carlyn Tan, David J Chung, O...> ;Leukemia & Lymphoma. 2022 Dec 1
• 2 citations
  Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.
  Karthik Nath, Ana Alarcon Tomas, Jessica Flynn, Joshua A Fein, Anna Alperovich, Theodora Anagnostou, Connie Lee Batlevi, Parastoo B Dahi, Warren B Fingrut, Sergio A Gi...> ;Transplantation and Cellular Therapy. 2022 Nov 1
• Join now to see all